{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd       \n",
    "from nltk.tokenize import sent_tokenize, RegexpTokenizer\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "# from nltk.stem.porter import PorterStemmer\n",
    "from nltk.corpus import stopwords\n",
    "# from nltk.sentiment.vader import SentimentIntensityAnalyzer\n",
    "import re\n",
    "import nltk\n",
    "import yfinance as yf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package vader_lexicon to\n",
      "[nltk_data]     /Users/cka/nltk_data...\n",
      "[nltk_data]   Package vader_lexicon is already up-to-date!\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "nltk.download('vader_lexicon')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "DatetimeIndex: 492 entries, 2009-08-17 12:14:00+00:00 to 2020-06-11 14:22:00+00:00\n",
      "Data columns (total 2 columns):\n",
      " #   Column     Non-Null Count  Dtype \n",
      "---  ------     --------------  ----- \n",
      " 0   headline   492 non-null    object\n",
      " 1   sentiment  492 non-null    object\n",
      "dtypes: object(2)\n",
      "memory usage: 11.5+ KB\n"
     ]
    }
   ],
   "source": [
    "merc_df = pd.read_csv('./data/merc_news.csv')\n",
    "merc_df['date'] = pd.to_datetime(merc_df['date'])\n",
    "merc_df.set_index('date', inplace=True)\n",
    "merc_df.sort_index(inplace=True)\n",
    "merc_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "DatetimeIndex: 3776 entries, 2009-05-18 00:00:00-04:00 to 2024-05-16 00:00:00-04:00\n",
      "Data columns (total 7 columns):\n",
      " #   Column        Non-Null Count  Dtype  \n",
      "---  ------        --------------  -----  \n",
      " 0   Open          3776 non-null   float64\n",
      " 1   High          3776 non-null   float64\n",
      " 2   Low           3776 non-null   float64\n",
      " 3   Close         3776 non-null   float64\n",
      " 4   Volume        3776 non-null   int64  \n",
      " 5   Dividends     3776 non-null   float64\n",
      " 6   Stock Splits  3776 non-null   float64\n",
      "dtypes: float64(6), int64(1)\n",
      "memory usage: 236.0 KB\n"
     ]
    }
   ],
   "source": [
    "merc = yf.Ticker('MERC')\n",
    "merc_stock_df = merc.history(period='15y')\n",
    "merc_stock_df.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Harpoon Therapeutics, Inc. (Nasdaq: HARP). Harpoon is now a wholly-owned subsidiary of Merck, and Harpoon’s common stock will no longer be publicly traded or listed on the Nasdaq Stock Market. Harpoon’s lead candidate, MK-6070 (formerly known as HPN328), is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand that is expressed at high levels in small cell lung cancer (SCLC) and neuroendocrine tumors. The safety, tolerability and pharmacokinetics of MK-6070 is currently being evaluated as monotherapy in a Phase 1/2 clinical trial (NCT04471727) in certain patients with advanced cancers associated with expression of DLL3. The study is also evaluating MK-6070 in combination with atezolizumab in certain patients with SCLC. In March 2022, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to MK-6070 for the treatment of SCLC.\n"
     ]
    }
   ],
   "source": [
    "# Define Merck text.\n",
    "text = 'Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of Harpoon Therapeutics, Inc. (Nasdaq: HARP). Harpoon is now a wholly-owned subsidiary of Merck, and Harpoon’s common stock will no longer be publicly traded or listed on the Nasdaq Stock Market. Harpoon’s lead candidate, MK-6070 (formerly known as HPN328), is a T-cell engager targeting delta-like ligand 3 (DLL3), an inhibitory canonical Notch ligand that is expressed at high levels in small cell lung cancer (SCLC) and neuroendocrine tumors. The safety, tolerability and pharmacokinetics of MK-6070 is currently being evaluated as monotherapy in a Phase 1/2 clinical trial (NCT04471727) in certain patients with advanced cancers associated with expression of DLL3. The study is also evaluating MK-6070 in combination with atezolizumab in certain patients with SCLC. In March 2022, the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to MK-6070 for the treatment of SCLC.'\n",
    "print(text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Open</th>\n",
       "      <th>High</th>\n",
       "      <th>Low</th>\n",
       "      <th>Close</th>\n",
       "      <th>Volume</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Date</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>2009-05-18 00:00:00-04:00</th>\n",
       "      <td>0.796483</td>\n",
       "      <td>0.825446</td>\n",
       "      <td>0.774761</td>\n",
       "      <td>0.796483</td>\n",
       "      <td>60400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-05-19 00:00:00-04:00</th>\n",
       "      <td>0.825446</td>\n",
       "      <td>0.825446</td>\n",
       "      <td>0.753038</td>\n",
       "      <td>0.760279</td>\n",
       "      <td>89100</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-05-20 00:00:00-04:00</th>\n",
       "      <td>0.796483</td>\n",
       "      <td>0.796483</td>\n",
       "      <td>0.709594</td>\n",
       "      <td>0.716834</td>\n",
       "      <td>262400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-05-21 00:00:00-04:00</th>\n",
       "      <td>0.709593</td>\n",
       "      <td>0.716834</td>\n",
       "      <td>0.615464</td>\n",
       "      <td>0.622704</td>\n",
       "      <td>118000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2009-05-22 00:00:00-04:00</th>\n",
       "      <td>0.622705</td>\n",
       "      <td>0.760279</td>\n",
       "      <td>0.622705</td>\n",
       "      <td>0.760279</td>\n",
       "      <td>251400</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                               Open      High       Low     Close  Volume\n",
       "Date                                                                     \n",
       "2009-05-18 00:00:00-04:00  0.796483  0.825446  0.774761  0.796483   60400\n",
       "2009-05-19 00:00:00-04:00  0.825446  0.825446  0.753038  0.760279   89100\n",
       "2009-05-20 00:00:00-04:00  0.796483  0.796483  0.709594  0.716834  262400\n",
       "2009-05-21 00:00:00-04:00  0.709593  0.716834  0.615464  0.622704  118000\n",
       "2009-05-22 00:00:00-04:00  0.622705  0.760279  0.622705  0.760279  251400"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merc_stock_df.drop(columns=['Dividends', 'Stock Splits'], inplace=True)\n",
    "merc_stock_df.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Pre-Processing \n",
    "\n",
    "- Remove special characters\n",
    "- Tokenizing\n",
    "- Lemmatizing/Stemming\n",
    "- Stop word removal"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['merck (nyse: mrk), known as msd outside of the united states and canada, today announced the completion of the acquisition of harpoon therapeutics, inc. (nasdaq: harp).',\n",
       " 'harpoon is now a wholly-owned subsidiary of merck, and harpoon’s common stock will no longer be publicly traded or listed on the nasdaq stock market.',\n",
       " 'harpoon’s lead candidate, mk-6070 (formerly known as hpn328), is a t-cell engager targeting delta-like ligand 3 (dll3), an inhibitory canonical notch ligand that is expressed at high levels in small cell lung cancer (sclc) and neuroendocrine tumors.',\n",
       " 'the safety, tolerability and pharmacokinetics of mk-6070 is currently being evaluated as monotherapy in a phase 1/2 clinical trial (nct04471727) in certain patients with advanced cancers associated with expression of dll3.',\n",
       " 'the study is also evaluating mk-6070 in combination with atezolizumab in certain patients with sclc.',\n",
       " 'in march 2022, the u.s. food and drug administration (fda) granted orphan drug designation to mk-6070 for the treatment of sclc.']"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sentence tokenizer  ## May affect NER\n",
    "headlines = sent_tokenize(text.lower())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "# # word tokenizer \n",
    "# word_tokenize(text.lower())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Lemmatizing & Stemming\n",
    "\n",
    "**Lemmatizing** and **stemming** are two forms of shortening words so we can combine similar forms of the same word.\n",
    "\n",
    "When we \"**lemmatize**\" data, we take words and attempt to return their *lemma*, or the base/dictionary form of a word."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Instantiate RegExp Tokenizer\n",
    "tokenizer = RegexpTokenizer('\\w+|\\$[\\d\\.]+|\\S+')\n",
    "\n",
    "# \"Run\" Tokenizer\n",
    "text_tokens = tokenizer.tokenize(text.lower())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Instantiate lemmatizer. \n",
    "lemmatizer = WordNetLemmatizer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Lemmatize tokens.\n",
    "tokens_lem = [lemmatizer.lemmatize(i) for i in text_tokens]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('as', 'a'),\n",
       " ('states', 'state'),\n",
       " ('therapeutics', 'therapeutic'),\n",
       " ('as', 'a'),\n",
       " ('levels', 'level'),\n",
       " ('tumors', 'tumor'),\n",
       " ('as', 'a'),\n",
       " ('patients', 'patient'),\n",
       " ('cancers', 'cancer'),\n",
       " ('patients', 'patient')]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Compare tokens to lemmatized version.\n",
    "# list(zip(text_tokens, tokens_lem))\n",
    "\n",
    "# Print only those lemmatized tokens that are different.\n",
    "[(text_tokens[i], tokens_lem[i]) for i in range(len(text_tokens)) if text_tokens[i] != tokens_lem[i]]"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Stop Word Removal"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Remove stopwords from \"text_tokens.\"\n",
    "no_stop_words = [token for token in text_tokens if token not in stopwords.words('english')]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['merck', '(nyse:', 'mrk', '),', 'known', 'msd', 'outside', 'united', 'states', 'canada', ',', 'today', 'announced', 'completion', 'acquisition', 'harpoon', 'therapeutics', ',', 'inc', '.', '(nasdaq:', 'harp', ').', 'harpoon', 'wholly', '-owned', 'subsidiary', 'merck', ',', 'harpoon', '’s', 'common', 'stock', 'longer', 'publicly', 'traded', 'listed', 'nasdaq', 'stock', 'market', '.', 'harpoon', '’s', 'lead', 'candidate', ',', 'mk', '-6070', '(formerly', 'known', 'hpn328', '),', '-cell', 'engager', 'targeting', 'delta', '-like', 'ligand', '3', '(dll3),', 'inhibitory', 'canonical', 'notch', 'ligand', 'expressed', 'high', 'levels', 'small', 'cell', 'lung', 'cancer', '(sclc)', 'neuroendocrine', 'tumors', '.', 'safety', ',', 'tolerability', 'pharmacokinetics', 'mk', '-6070', 'currently', 'evaluated', 'monotherapy', 'phase', '1', '/2', 'clinical', 'trial', '(nct04471727)', 'certain', 'patients', 'advanced', 'cancers', 'associated', 'expression', 'dll3', '.', 'study', 'also', 'evaluating', 'mk', '-6070', 'combination', 'atezolizumab', 'certain', 'patients', 'sclc', '.', 'march', '2022', ',', 'u', '.s.', 'food', 'drug', 'administration', '(fda)', 'granted', 'orphan', 'drug', 'designation', 'mk', '-6070', 'treatment', 'sclc', '.']\n"
     ]
    }
   ],
   "source": [
    "# Check it\n",
    "print(no_stop_words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "ga",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
